Skip to main navigation Skip to search Skip to main content

Effect of growth-promoting 17beta-estradiol, 19-nortestosterone and dexamethasone on circulating levels of nine potential biomarker candidates in veal calves.

  • G. Cacciatore
  • , S.W. Eisenberg
  • , C. Situ
  • , M.H. Mooney
  • , P. Delahaut
  • , S. Klarenbeek
  • , A.C. Huet
  • , A.A. Bergwerff
  • , C.T. Elliott
    • extern

    Research output: Contribution to journal › Article › Academic › peer-review

    Abstract

    The use of screening methods based on the detection of biological effects of growth promoters is a promising approach to assist residue monitoring. To reveal useful effects on protein metabolism, male and female veal calves at 10 weeks of age were treated thrice with a combination of 25mg 17beta-estradiol 3-benzoate and 150 mg 19-nortestosterone decanoate with 2 weeks intervals and finally once with 4 mg dexamethasone. Hormone-treated calves showed a significant accelerated growth rate over 6 weeks. Plasma samples of treated and control calves were analysed for immunoreactive inhibin (ir-inhibin), osteocalcin, insulin-like growth factor 1 (IGF-1), insulin-like growth factor-binding protein 2 (IGFBP-2), IGFBP-3, luteinzing hormone (LH), follicle-stimulating hormone (FSH) and prolactin using immunoaffinity assays. Hormone treatment did not affect levels of IGF-1, IGFBP-2, IGFBP-3, LH, FSH and prolactin. The concentration of circulating ir-inhibin decreased, however, significantly (P
    Original languageUndefined/Unknown
    Pages (from-to)351-359
    Number of pages9
    JournalAnalytica Chimica Acta
    Volume637
    Issue number1-2
    Publication statusPublished - 2009

    Cite this